Related Experiment Videos
Brachial plexus neurotization with donor phrenic nerves and its effect on pulmonary function
Wolf Luedemann1, Michael Hamm, Ulrike Blömer
1Department of Neurosurgery, Medical School Hannover, Germany. Luedemann.Wolf@MH-Hannover.de
Journal of Neurosurgery
|March 9, 2002
Summary
Phrenic nerve transfers for brachial plexus injury can reduce pulmonary function, especially when using the right phrenic nerve. Preoperative assessment of maximal inspiratory pressure is crucial for patients undergoing these neurotizations.
Area of Science:
- Neurosurgery
- Pulmonary Medicine
- Orthopedic Surgery
Background:
- Brachial plexus injuries and root avulsions often require reconstructive surgery.
- Neurotization procedures utilize donor nerves to restore function.
- The phrenic nerve is a potential donor nerve for neurotization, but its impact on pulmonary function is not fully understood.
Purpose of the Study:
- To evaluate the pulmonary side effects of neurotization procedures using the phrenic nerve.
- To compare pulmonary function before and after surgery in patients with brachial plexus injury.
Main Methods:
- Twenty-three patients with complete brachial plexus palsy underwent neurotization using the phrenic nerve.
- Pulmonary function tests, including vital capacity and maximal inspiratory pressure, were performed pre- and postoperatively.
- Body plethysmography was conducted more than 12 months after surgery in 12 patients.
Main Results:
- No immediate postoperative pulmonary complications were observed.
- A significant reduction in vital capacity (9.8%) was noted across all patients.
- Right-sided phrenic nerve transfers resulted in a significant vital capacity reduction (14.3%), while left-sided transfers showed a nonsignificant reduction (3.6%).
Conclusions:
- Using the right phrenic nerve for neurotization increases the risk of reduced pulmonary vital capacity.
- Preference should be given to the left phrenic nerve when possible.
- Preoperative measurement of maximal inspiratory pressure is recommended to identify patients at risk for further pulmonary decline.